74 related articles for article (PubMed ID: 950429)
21. Vanoxonin, a new inhibitor of thymidylate synthetase.
Kanai F; Sawa T; Hamada M; Naganawa H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1983 Jun; 36(6):656-60. PubMed ID: 6874588
[TBL] [Abstract][Full Text] [Related]
22. 5-chloro-2'-deoxyuridine cytotoxicity results from base excision repair of uracil subsequent to thymidylate synthase inhibition.
Brandon ML; Mi L; Chaung W; Teebor G; Boorstein RJ
Mutat Res; 2000 Mar; 459(2):161-9. PubMed ID: 10725666
[TBL] [Abstract][Full Text] [Related]
23. Vanoxonin, a new inhibitor of thymidylate synthetase. III. Inhibition of thymidylate synthetase by vanoxonin-vanadium complex.
Kanai F; Kaneko T; Morishima H; Isshiki K; Takita T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1985 Jan; 38(1):39-50. PubMed ID: 3972727
[TBL] [Abstract][Full Text] [Related]
24. Role of thymidine kinase and thymidylate synthetase in the cytostatic, antimetabolic, and antitumor effects of the carbocyclic analogue of 5-nitro-2'-deoxyuridine. A comparison with 5-nitro-2'-deoxyuridine.
Balzarini J; De Clercq E; Herdewijn P; Robins MJ
Mol Pharmacol; 1985 May; 27(5):578-83. PubMed ID: 3990680
[TBL] [Abstract][Full Text] [Related]
25. Thymidylate synthase inhibition in cells with arrested DNA synthesis is not due to an allosteric interaction in the replitase complex.
Rode W; Jastreboff MM; Bertino JR
Biochem Biophys Res Commun; 1985 Apr; 128(1):345-51. PubMed ID: 3921023
[TBL] [Abstract][Full Text] [Related]
26. Assessment of growth-limiting events caused by 5-fluorouracil in mouse cells and in human cells.
Evans RM; Laskin JD; Hakala MT
Cancer Res; 1980 Nov; 40(11):4113-22. PubMed ID: 6162543
[No Abstract] [Full Text] [Related]
27. Biochemical and antitumor effects of 5,8-dideazaisopteroylglutamate, a unique quinazoline inhibitor of thymidylate synthase.
Fernandes DJ; Bertino JR; Hynes JB
Cancer Res; 1983 Mar; 43(3):1117-23. PubMed ID: 6825083
[No Abstract] [Full Text] [Related]
28. Inhibition of thymidylate synthetase of the human lymphocytes.
Haurani FI
Cancer Biochem Biophys; 1979; 4(2):75-7. PubMed ID: 317899
[TBL] [Abstract][Full Text] [Related]
29. Human thymidylate synthetase--III. Effects of methotrexate and folate analogs.
Szeto DW; Cheng YC; Rosowsky A; Yu CS; Modest EJ; Piper JR; Temple C; Elliott RD; Rose JD; Montgomery JA
Biochem Pharmacol; 1979 Sep; 28(17):2633-7. PubMed ID: 518674
[No Abstract] [Full Text] [Related]
30. Plasma nucleoside and base levels following treatment with the new thymidylate synthetase inhibitor CB 3717.
Taylor GA; Jackman AL; Calvert AH; Harrap KR
Adv Exp Med Biol; 1984; 165 Pt B():379-82. PubMed ID: 6720435
[No Abstract] [Full Text] [Related]
31. [Studies on the mechanism of antitumor activity of 5-FU and its derivatives--relationship between the inhibition of tumor growth and the inhibition of thymidylate synthetase in vivo].
Nakamura H; Yu-Qin W; Miyauchi S; Nishioka N; Tanaka H; Harada N; Shirasaka T; Fujii S
Gan To Kagaku Ryoho; 1984 May; 11(5):1049-55. PubMed ID: 6426401
[TBL] [Abstract][Full Text] [Related]
32. Nonenzymatic exchange of tritium from (5-3H) deoxyuridylate in the thymidylate synthetase assay.
Kawai M; Hillcoat BL
Anal Biochem; 1974 Apr; 58(2):404-13. PubMed ID: 4827389
[No Abstract] [Full Text] [Related]
33. Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-(( 2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino) benzoyl)-L-glutamic acid (CB3717), on human lymphoblastoid cells.
Jackson RC; Jackman AL; Calvert AH
Biochem Pharmacol; 1983 Dec; 32(24):3783-90. PubMed ID: 6661252
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of thymidylate synthetase by the new quinazoline antifolate, CB 3717; enzyme purification and kinetics.
Jackman AL; Calvert AH; Hart LI; Harrap KR
Adv Exp Med Biol; 1984; 165 Pt B():375-8. PubMed ID: 6720434
[No Abstract] [Full Text] [Related]
35. Properties and inhibition of thymidylate synthetase in Drosophila melanogaster.
Carpenter NJ
J Insect Physiol; 1974 Jul; 20(7):1389-401. PubMed ID: 4212277
[No Abstract] [Full Text] [Related]
36. Studies on the interaction with thymidylate synthase of analogues of 2'-deoxyuridine-5'-phosphate and 5-fluoro-2'-deoxyuridine-5'-phosphate with modified phosphate groups.
Rode W; Kulikowski T; Kedzierska B; Shugar D
Biochem Pharmacol; 1987 Jan; 36(2):203-10. PubMed ID: 3814166
[TBL] [Abstract][Full Text] [Related]
37. Proceedings: Inhibitors of thymidylate synthetase as R factor curing agents.
Bremer K; Pinney RJ; Smith JT
J Pharm Pharmacol; 1973 Dec; 25():Suppl:131P-132. PubMed ID: 4150531
[No Abstract] [Full Text] [Related]
38. Vanoxonin, a new inhibitor of thymidylate synthetase. II. Structure determination and total synthesis.
Kanai F; Isshiki K; Umezawa Y; Morishima H; Naganawa H; Takita T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1985 Jan; 38(1):31-8. PubMed ID: 3972726
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of thymidylate synthetase of Walker carcinoma by chlorambucil. A possible mechanism of action.
Srinivasan SK; Gupta VS; Howarth RE
Biochem Pharmacol; 1977 Jun; 26(11):1027-32. PubMed ID: 880254
[No Abstract] [Full Text] [Related]
40. Quinazoline antifolates as inhibitors of growth, dihydrofolate reductase, and thymidylate synthetase of mouse neuroblastoma cells in culture.
Carlin SC; Rosenberg RN; VandeVenter L; Friedkin M
Mol Pharmacol; 1974 Mar; 10(2):194-203. PubMed ID: 4546895
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
